IGF2BP2 activates the RhoA-ROCK pathway by recognizing the m6A methylation site on insulin-like growth factor 1 receptor(IGF1R) mRNA, enhancing the proliferation, migration, and invasion of gastric cancer cells while reducing their tendency to undergo apoptosis [76]. Here, IGF2BP2 is linked to gastric cancer.